D-0050-2027 Class II Ongoing
FDA drug recall D-0050-2027 was initiated by Shenzhen Techdow Pharmaceutical Co., Ltd. on Oct 1, 2026 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is ongoing. Affected quantity: 251,000 1 mL multidose vials.
Recall details
- Product Type
- Drugs
- Report Date
- Oct 28, 2026
- Initiation Date
- Oct 1, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 251,000 1 mL multidose vials
Product description
Heparin Sodium Injection, USP, 5,000 USP Units/mL, 1mL Multi dose vial x 25 vials per carton, Distributed by: Hepalink USA Inc., Langhome, PA 19047-1885. Carton NDC: NDC 81952-111-06, Vial NDC: 81942-111-01
Reason for recall
Lack of Assurance of Sterility
Distribution pattern
Nationwide in the USA.
Code information
Lot# CU03232A, Exp 1/31/2028
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0050-2027
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026